首页> 外文期刊>Journal of Neurodegenerative Diseases >Neurodegenerative Diseases: Multifactorial Conformational Diseases and Their Therapeutic Interventions
【24h】

Neurodegenerative Diseases: Multifactorial Conformational Diseases and Their Therapeutic Interventions

机译:神经退行性疾病:多因素构象性疾病及其治疗干预

获取原文
       

摘要

Neurodegenerative diseases are multifactorial debilitating disorders of the nervous system that affect approximately 30 millionindividuals worldwide. Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis diseases are the consequence of misfolding and dysfunctional trafficking of proteins. Beside that, mitochondrial dysfunction, oxidative stress, and/or environmental factors strongly associated with age have also been implicated in causing neurodegeneration. After years of intensive research, considerable evidence has accumulated that demonstrates an important role of these factors in the etiology of common neurodegenerative diseases. Despite the extensive efforts that have attempted to define the molecular mechanisms underlying neurodegeneration, many aspects of these pathologies remain elusive. However, in order to explore the therapeutic interventions directed towards treatment of neurodegenerative diseases, neuroscientists are now fully exploiting the data obtained from studies of these basic mechanisms that have gone awry. The novelty of these mechanisms represents a challenge to the identification of viable drug targets and biomarkers for early diagnosis of the diseases. In this paper, we are reviewing various aspects associated with the disease and the recent trends that may have an application for the treatment of the neurodegenerative disorders.
机译:神经退行性疾病是神经系统的多因素衰弱性疾病,影响全球约3000万人。诸如阿尔茨海默氏症,帕金森氏症,亨廷顿氏症和肌萎缩性侧索硬化症等神经退行性疾病是蛋白质折叠错误和功能失调的结果。除此之外,与年龄密切相关的线粒体功能障碍,氧化应激和/或环境因素也与神经变性有关。经过多年的深入研究,已积累了大量证据,证明了这些因素在常见神经退行性疾病的病因学中的重要作用。尽管已做出大量努力来试图确定神经退行性病变的分子机制,但这些病理的许多方面仍然难以捉摸。然而,为了探索针对神经退行性疾病治疗的治疗性干预措施,神经科学家现在正在充分利用从研究这些基本机理的经验中获得的数据。这些机制的新颖性代表着对用于疾病早期诊断的可行药物靶标和生物标记物鉴定的挑战。在本文中,我们正在审查与疾病相关的各个方面以及可能在神经退行性疾病的治疗中应用的最新趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号